A study on the mechanism of action of B7H4 in HER2-positive gastric cancer and its sensitivity to trastuzumab therapy
Qiangzu Shao, Fan Zhang, Wenjie Wang, Zeping Huang · 2026
Read A study on the mechanism of action of B7H4 in HER2-positive gastric cancer and its sensitivity to trastuzumab therapy by Qiangzu Shao, Fan Zhang, Wenjie Wang, Zeping Huang (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13559659.txt.
Description
Qiangzu Shao and three colleagues examine B7H4, an immune checkpoint protein, in HER2-positive gastric cancer and its effect on response to trastuzumab, the standard targeted drug for this subtype. Their 2026 study moves from cancer atlas data and tissue staining to knockdown experiments in a co-expressing cell line. Resistance to trastuzumab, both initial and acquired, is a central problem in this disease.
Staining showed B7H4 and HER2 appearing together in tumors, their levels positively correlated. B7H4 abundance also tracked with larger tumors, deeper invasion, and spread to nodes and distant sites. Silencing B7H4 in NCI-N87 cells curbed their growth, migration, and invasion to varying degrees. Gene sequencing after knockdown shifted programs for proliferation and movement, and the team tested whether drug sensitivity changed as well. The authors frame B7H4 as a resistance lever worth targeting alongside HER2 therapy.
Catalog record
| CREATOR | Qiangzu Shao, Fan Zhang, Wenjie Wang, Zeping Huang |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 52844 |
| LICENSE | https://creativecommons.org/licenses/by/4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |